Aggregated
80% success rate- Bullish
- 0
- Hold
- 7
- Bearish
- 0
Citigroup
A Citigroup analyst with 18 tracked ratings across 18 distinct tickers has a hold count of 7 and an 80% success rate on the captured sample, focusing exclusively on the relevant source category.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| MANE | 2026-05-18 | buy | $135.00 | Aggregated |
| REGN | 2026-05-18 | hold | $700.00 | Aggregated |
| RPRX | 2026-05-07 | buy | $66.00 | Aggregated |
| MRK | 2026-05-06 | hold | $125.00 | Aggregated |
| BIIB | 2026-05-01 | hold | $200.00 | Aggregated |
| KNSA | 2026-04-29 | buy | $60.00 | Aggregated |
| PFE | 2026-04-29 | hold | $27.00 | Aggregated |
| BIIB | 2026-04-13 | hold | $190.00 | Aggregated |
| GILD | 2026-04-13 | buy | $165.00 | Aggregated |
| APGE | 2026-03-24 | buy | $125.00 | Aggregated |
| MRK | 2026-03-20 | hold | $125.00 | Aggregated |
| PTGX | 2026-03-19 | buy | $125.00 | Aggregated |
| BNTX | 2026-03-11 | buy | $130.00 | Aggregated |
| VRTX | 2026-03-10 | buy | $585.00 | Aggregated |
| SRRK | 2026-03-04 | buy | $58.00 | Aggregated |
| KYMR | 2026-03-02 | buy | $120.00 | Aggregated |
| ACLX | 2026-02-24 | hold | $115.00 | Aggregated |
| BIIB | 2026-02-09 | hold | $215.00 | Aggregated |
| BMY | 2026-02-06 | hold | $64.00 | Aggregated |
| AMGN | 2026-02-04 | hold | $345.00 | Aggregated |
| MRK | 2026-02-04 | hold | $120.00 | Aggregated |
| ABBV | 2026-01-27 | hold | $230.00 | Aggregated |
| GILD | 2026-01-27 | buy | $156.00 | Aggregated |
| MRK | 2026-01-27 | hold | $115.00 | Aggregated |
| RPRX | 2026-01-27 | buy | $50.00 | Aggregated |
| SRRK | 2026-01-09 | buy | $55.00 | Aggregated |
| VOR | 2026-01-09 | buy | $50.00 | Aggregated |
| GILD | 2026-01-07 | buy | $140.00 | Aggregated |
| MRK | 2026-01-07 | hold | $110.00 | Aggregated |
| KYMR | 2025-12-09 | buy | $110.00 | Aggregated |
| PTGX | 2025-12-08 | buy | $115.00 | Aggregated |
| PFE | 2025-12-02 | hold | $26.00 | Aggregated |
| PTGX | 2025-11-10 | buy | $98.00 | Aggregated |
| PTCT | 2025-11-05 | hold | $75.00 | Aggregated |
| PTCTPTC THERAPEUTICS INC | 2025-11-05 | hold | $75.00 | Aggregated |
| ABBV | 2025-11-03 | hold | $235.00 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 2025-10-29 | unknown | $700.00 | Aggregated |
| RNA | 2025-10-27 | hold | $72.00 | Aggregated |
| RNAAVIDITY BIOSCIENCES INC | 2025-10-27 | hold | $72.00 | Aggregated |
| MRNA | 2025-10-23 | hold | $28.00 | Aggregated |
| MRNAMODERNA INC | 2025-10-23 | hold | $28.00 | Aggregated |
| AMLX | 2025-10-17 | buy | $20.00 | Aggregated |
| KNSA | 2025-10-17 | buy | $50.00 | Aggregated |
| PTGX | 2025-10-17 | buy | $96.00 | Aggregated |
| MRK | 2025-10-13 | hold | $95.00 | Aggregated |
| MRKMERCK & CO INC | 2025-10-13 | hold | $95.00 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 2025-10-08 | unknown | $135.00 | Aggregated |
| VRTXVERTEX PHARMACEUTICALS, INC. | 2025-10-02 | unknown | $575.00 | Aggregated |
| AMGNAMGEN INC. | 2025-08-06 | hold | $310.00 | Aggregated |
| RPRX | 2025-07-22 | buy | $42.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| MANE | 1 | 2026-05-18 | Aggregated |
| REGN | 1 | 2026-05-18 | Aggregated |
| RPRX | 3 | 2026-05-07 | Aggregated |
| MRK | 6 | 2026-05-06 | Aggregated |
| BIIB | 3 | 2026-05-01 | Aggregated |
| KNSA | 3 | 2026-04-29 | Aggregated |
| PFE | 2 | 2026-04-29 | Aggregated |
| GILD | 3 | 2026-04-13 | Aggregated |
| APGE | 2 | 2026-03-24 | Aggregated |
| PTGX | 4 | 2026-03-19 | Aggregated |
| BNTX | 1 | 2026-03-11 | Aggregated |
| VRTX | 1 | 2026-03-10 | Aggregated |
| SRRK | 2 | 2026-03-04 | Aggregated |
| KYMR | 2 | 2026-03-02 | Aggregated |
| ACLX | 2 | 2026-02-24 | Aggregated |
| BMY | 1 | 2026-02-06 | Aggregated |
| AMGN | 1 | 2026-02-04 | Aggregated |
| ABBV | 2 | 2026-01-27 | Aggregated |
| VOR | 1 | 2026-01-09 | Aggregated |
| PTCT | 1 | 2025-11-05 | Aggregated |
| PTCTPTC THERAPEUTICS INC | 1 | 2025-11-05 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 1 | 2025-10-29 | Aggregated |
| RNA | 2 | 2025-10-27 | Aggregated |
| RNAAVIDITY BIOSCIENCES INC | 1 | 2025-10-27 | Aggregated |
| MRNA | 1 | 2025-10-23 | Aggregated |
| MRNAMODERNA INC | 1 | 2025-10-23 | Aggregated |
| AMLX | 2 | 2025-10-17 | Aggregated |
| MRKMERCK & CO INC | 1 | 2025-10-13 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 1 | 2025-10-08 | Aggregated |
| VRTXVERTEX PHARMACEUTICALS, INC. | 1 | 2025-10-02 | Aggregated |
| AMGNAMGEN INC. | 1 | 2025-08-06 | Aggregated |
| RPRXROYALTY PHARMA PLC - ORDINARY SHARES - CLASS A | 1 | 2025-07-22 | Aggregated |
| ABOS | 1 | 2025-06-17 | Aggregated |
| ABOSACUMEN PHARMACEUTICALS INC | 1 | 2025-06-17 | Aggregated |
| ACLXARCELLX INC | 1 | 2025-06-17 | Aggregated |
| AMLXAMYLYX PHARMACEUTICALS INC | 1 | 2025-06-17 | Aggregated |
| NAMSNEWAMSTERDAM PHARMA COMPANY NV | 1 | 2025-06-17 | Aggregated |
| NVAXNOVAVAX, INC. | 1 | 2025-06-17 | Aggregated |
| PTGXPROTAGONIST THERAPEUTICS INC | 1 | 2025-06-17 | Aggregated |
| ABBVABBVIE INC | 1 | 2025-05-14 | Aggregated |
| BNTXBIONTECH SE - ADR | 1 | 2025-05-06 | Aggregated |
| BIIBBIOGEN INC | 1 | 2025-02-13 | Aggregated |